Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin vs. Other GHRH Analogs: A Comparison

Researchers working with the GH axis have several GHRH analog options. Choosing the right one depends on the specific research question. The table below summarizes the key structural and functional differences. Sequence Length 44 amino acids (full GHRH) 29 ami

This comparison does not assign a generated winner or score.

  • Researchers working with the GH axis have several GHRH analog options. Choosing the right one depends on the specific research question. The table below summarizes the key structural and functional differences.
  • Sequence Length
  • 44 amino acids (full GHRH)
  • 29 amino acids (truncated)
  • 29 amino acids + DAC modification
  • N-Terminal Modification
  • Trans-3-hexenoic acid
  • None
  • Drug Affinity Complex (DAC)
  • DPP-IV Resistance
  • High
  • Low
  • High (via albumin binding)
  • Approximate Half-Life
  • Hours (extended vs. native)
  • Minutes (rapidly cleaved)
  • Days (albumin-bound reservoir)
  • GH Secretion Pattern
  • Pulsatile, physiological
  • Pulsatile, shorter duration
  • Prolonged, blunted pulse amplitude
  • Receptor Desensitization Risk
  • Moderate (with repeated dosing)
  • Lower (shorter exposure)
  • Higher (extended receptor occupancy)
  • Best Research Use Case
  • Receptor binding studies, pulsatile GH assays, IGF-1 induction
  • Acute GH response studies, DPP-IV susceptibility comparisons
  • Long-duration exposure studies, steady-state IGF-1 models
  • The choice between these compounds is not simply a matter of potency. If the research question involves studying pulsatile GH secretion in a pattern that approximates endogenous rhythm, tesamorelin is generally a better fit than CJC-1295, which can suppress normal GH pulsatility through prolonged receptor engagement. If the research requires a short-acting standard for comparative work, sermorelin may be more appropriate.
  • For detailed head-to-head analysis of these compounds, see: - Tesamorelin vs Sermorelin: A Structural and Functional Comparison for Preclinical Research - Tesamorelin vs CJC-1295: Comparing GHRH Analogs for Preclinical Research Applications